170 related articles for article (PubMed ID: 8940374)
1. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
[TBL] [Abstract][Full Text] [Related]
2. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
[TBL] [Abstract][Full Text] [Related]
4. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
McPherson SJ; Thomas TZ; Wang H; Gurusinghe CJ; Risbridger GP
J Endocrinol; 1997 Sep; 154(3):535-45. PubMed ID: 9379131
[TBL] [Abstract][Full Text] [Related]
6. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
Zhang Z; Zhao Y; Batres Y; Lin MF; Ying SY
Biochem Biophys Res Commun; 1997 May; 234(2):362-5. PubMed ID: 9177276
[TBL] [Abstract][Full Text] [Related]
7. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
8. Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth.
Carey JL; Sasur LM; Kawakubo H; Gupta V; Christian B; Bailey PM; Maheswaran S
Mol Endocrinol; 2004 Mar; 18(3):696-707. PubMed ID: 14684851
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
10. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate branching morphogenesis by activin A and follistatin.
Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
[TBL] [Abstract][Full Text] [Related]
12. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
Delbaere A; Sidis Y; Schneyer AL
Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
[TBL] [Abstract][Full Text] [Related]
13. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
Kaipia A; Toppari J; Huhtaniemi I; Paranko J
Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
[TBL] [Abstract][Full Text] [Related]
14. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
Erämaa M; Hildén K; Tuuri T; Ritvos O
Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes.
Zhang YQ; Kanzaki M; Mashima H; Mine T; Kojima I
Hepatology; 1996 Feb; 23(2):288-93. PubMed ID: 8591854
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
Lu S; Tsai SY; Tsai MJ
Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
[TBL] [Abstract][Full Text] [Related]
17. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
[TBL] [Abstract][Full Text] [Related]
18. Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo.
Tanaka A; Hasegawa Y; Hakamata Y; Kamiakito T; Kuriki K; Yoshida H; Fukayama M
J Cell Physiol; 2001 Aug; 188(2):194-200. PubMed ID: 11424086
[TBL] [Abstract][Full Text] [Related]
19. Activin stimulates proliferation of rat ovarian thecal-interstitial cells.
Duleba AJ; Pehlivan T; Carbone R; Spaczynski RZ
Biol Reprod; 2001 Sep; 65(3):704-9. PubMed ID: 11514331
[TBL] [Abstract][Full Text] [Related]
20. Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCAP: role of interleukin-6.
Okamoto M; Lee C; Oyasu R
Endocrinology; 1997 Nov; 138(11):5071-4. PubMed ID: 9348243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
